Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection
Staphylococcus aureus is the leading cause of nosocomial and community-acquired infections, including soft tissue and skin infections and bacteremia. However, efforts to develop an effective vaccine against S. aureus infections have not been successful. We evaluated serotypes 5 and 8 capsule polysac...
Päätekijät: | Brian L. Cheng, Travis B. Nielsen, Paul Pantapalangkoor, Fan Zhao, Jean C. Lee, Christopher P. Montgomery, Brian Luna, Brad Spellberg, Robert S. Daum |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Taylor & Francis Group
2017-07-01
|
Sarja: | Human Vaccines & Immunotherapeutics |
Aiheet: | |
Linkit: | http://dx.doi.org/10.1080/21645515.2017.1304334 |
Samankaltaisia teoksia
-
O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide
Tekijä: Ingrid L. Scully, et al.
Julkaistu: (2018-01-01) -
Conjugation of Synthetic Trisaccharide of Staphylococcus aureus Type 8 Capsular Polysaccharide Elicits Antibodies Recognizing Intact Bacterium
Tekijä: Ming Zhao, et al.
Julkaistu: (2020-04-01) -
Antimicrobial resistance and molecular typing of Staphylococcus aureus isolates from raw milk in Hunan Province
Tekijä: Keming Ning, et al.
Julkaistu: (2023-08-01) -
Capsular polysaccharide determines the serotyping of Riemerella anatipestifer
Tekijä: Yanling Liu, et al.
Julkaistu: (2023-12-01) -
Optimization of manufacturing process for serotype 14 pneumococcal capsular polysaccharide
Tekijä: Yuelong Li, et al.
Julkaistu: (2024-10-01)